ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in ImageneBio, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 58
- +6 vs. Q2 2023
- Shares held
- 32.7M
- +1.51M (+4.8%) vs. Q2 2023
- Total value
- $141.6M
- −$63.1M (−30.8%) vs. Q2 2023
- New holders
- 9
- 25 more added
- Sold out
- 3
- 9 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 10 | $43 | 0.00% | −6,321−99.8% | Reduced |
| Farther Finance Advisors, LLC | 50 | $217 | 0.00% | 00.0% | Unchanged |
| Allspring Global Investments Holdings, LLC | 1,678 | $7.26K | 0.00% | +1,678 | New |
| Ameritas Investment Partners, Inc. | 1,755 | $7.60K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 2,045 | $8.86K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 2,068 | $9.00K | 0.00% | 00.0% | Unchanged |
| Baystate Wealth Management LLC | 2,999 | $13.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,713 | $16.1K | 0.00% | +2,797+305.3% | Added |
| Royal Bank of Canada | 4,282 | $18.0K | 0.00% | +1,645+62.4% | Added |
| California State Teachers Retirement System | 5,480 | $23.7K | 0.00% | −1,592−22.5% | Reduced |
| Wells Fargo & Company | 6,130 | $26.5K | 0.00% | −2,097−25.5% | Reduced |
| Acadian Asset Management LLC | 10,198 | $44.0K | 0.00% | −1,190−10.4% | Reduced |
| SG Americas Securities, LLC | 10,727 | $46.0K | 0.00% | +10,727 | New |
| Voya Investment Management LLC | 11,176 | $48.4K | 0.00% | +11,176 | New |
| Virtu Financial LLC | 11,675 | $51.0K | 0.01% | +11,675 | New |
| American International Group, Inc. | 12,394 | $53.7K | 0.00% | +2,162+21.1% | Added |
| Mirae Asset Global Investments Co., Ltd. | 12,687 | $54.9K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 13,094 | $57.0K | 0.00% | −1,000−7.1% | Reduced |
| UBS Group AG | 13,660 | $59.1K | 0.00% | +1,316+10.7% | Added |
| New York State Common Retirement Fund | 15,062 | $65.2K | 0.00% | +262+1.8% | Added |
| Morgan Stanley | 15,715 | $68.0K | 0.00% | +728+4.9% | Added |
| JPMorgan Chase & Co | 16,478 | $71.3K | 0.00% | −1,340−7.5% | Reduced |
| Goldman Sachs Group Inc | 21,389 | $92.6K | 0.00% | +3,639+20.5% | Added |
| Two Sigma Investments, LP | 21,729 | $94.1K | 0.00% | +21,729 | New |
| Rhumbline Advisers | 25,378 | $109.9K | 0.00% | +3,950+18.4% | Added |
| OUP Management Co., LLC | 26,833 | $116.2K | 0.26% | +26,833 | New |
| Bank of America Corp | 29,776 | $128.9K | 0.00% | +14,153+90.6% | Added |
| Nuveen Asset Management, LLC | 33,023 | $143.0K | 0.00% | 00.0% | Unchanged |
| Cornercap Investment Counsel Inc | 37,244 | $161.3K | 0.03% | −1,104−2.9% | Reduced |
| Fred Alger Management, LLC | 42,916 | $185.8K | 0.00% | +1,664+4.0% | Added |
| Jacobs Levy Equity Management, Inc | 57,246 | $247.9K | 0.00% | +29,426+105.8% | Added |
| Bank of New York Mellon Corp | 69,239 | $299.8K | 0.00% | +6,901+11.1% | Added |
| Charles Schwab Investment Management Inc | 69,734 | $301.9K | 0.00% | +9,076+15.0% | Added |
| Dimensional Fund Advisors LP | 85,615 | $370.7K | 0.00% | +26,501+44.8% | Added |
| Ensign Peak Advisors, Inc | 90,310 | $391.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 114,650 | $496.4K | 0.01% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 115,712 | $501.0K | 0.03% | +115,712 | New |
| NEA Management Company, LLC | 181,473 | $707.2K | 0.05% | +181,473 | New |
| Northern Trust Corp | 198,012 | $857.4K | 0.00% | +20,668+11.7% | Added |
| Barclays PLC | 206,545 | $894.3K | 0.00% | +4,343+2.1% | Added |
| Citadel Advisors LLC | 206,737 | $895.2K | 0.00% | +168,616+442.3% | Added |
| Vida Ventures Advisors, LLC | 225,192 | $975.1K | 1.51% | +225,192 | New |
| State Street Corp | 397,045 | $1.72M | 0.00% | +13,191+3.4% | Added |
| Adage Capital Partners GP, L.L.C. | 407,900 | $1.77M | 0.00% | +20,000+5.2% | Added |
| Geode Capital Management, LLC | 517,216 | $2.24M | 0.00% | +50,017+10.7% | Added |
| Laurion Capital Management LP | 534,657 | $2.32M | 0.06% | +17,094+3.3% | Added |
| Acuta Capital Partners, LLC | 551,010 | $2.39M | 1.73% | −6,990−1.3% | Reduced |
| Vanguard Group Inc | 1,352,984 | $5.86M | 0.00% | +257,814+23.5% | Added |
| BlackRock Inc. | 1,446,195 | $6.26M | 0.00% | +178,852+14.1% | Added |
| Avoro Capital Advisors LLC | 1,640,000 | $7.10M | 0.11% | 00.0% | Unchanged |
| Verition Fund Management LLC | 1,721,689 | $7.45M | 0.10% | +660,581+62.3% | Added |
| Artal Group S.A. | 1,849,513 | $8.01M | 0.35% | 00.0% | Unchanged |
| CHI Advisors LLC | 2,180,934 | $9.44M | 3.75% | +58,894+2.8% | Added |
| Omega Fund Management, LLC | 2,249,123 | $9.74M | 8.94% | 00.0% | Unchanged |
| BVF Inc | 3,169,164 | $13.7M | 0.37% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,186,166 | $13.8M | 0.32% | 00.0% | Unchanged |
| FMR LLC | 4,458,134 | $19.3M | 0.00% | −612,688−12.1% | Reduced |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $21.7M | 3.37% | 00.0% | Unchanged |
| MetLife Investment Management | 0 | $0 | 0.00% | −12,121−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,256−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −218−100.0% | Sold out |